Your browser doesn't support javascript.
loading
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy.
Miller, Peter G; Sperling, Adam S; Mayerhofer, Christina; McConkey, Marie E; Ellegast, Jana M; Da Silva, Carmen; Cohen, Drew N; Wang, Chuqi; Sharda, Azeem; Yan, Ni; Saha, Subha; Schluter, Cameron; Schechter, Ilexa; Slabicki, Mikolaj; Sandoval, Brittany; Kahn, Josephine; Boettcher, Steffen; Gibson, Christopher J; Scadden, David T; Stegmaier, Kimberly; Bhatt, Shruti; Lindsley, R Coleman; Ebert, Benjamin L.
Afiliação
  • Miller PG; Center for Cancer Research, Massachusetts General Hospital, Boston, MA.
  • Sperling AS; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.
  • Mayerhofer C; Harvard Medical School, Boston, MA.
  • McConkey ME; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Ellegast JM; Harvard Medical School, Boston, MA.
  • Da Silva C; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Cohen DN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Wang C; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
  • Sharda A; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.
  • Yan N; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Saha S; Harvard Stem Cell Institute, Harvard University, Cambridge, MA.
  • Schluter C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Schechter I; Harvard Medical School, Boston, MA.
  • Slabicki M; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Sandoval B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Kahn J; Center for Cancer Research, Massachusetts General Hospital, Boston, MA.
  • Boettcher S; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.
  • Gibson CJ; Harvard Medical School, Boston, MA.
  • Scadden DT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Stegmaier K; National University of Singapore, Singapore.
  • Bhatt S; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.
  • Lindsley RC; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
  • Ebert BL; Center for Cancer Research, Massachusetts General Hospital, Boston, MA.
Blood ; 142(24): 2079-2091, 2023 12 14.
Article em En | MEDLINE | ID: mdl-37595362
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Proteína Supressora de Tumor p53 Limite: Adult / Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Proteína Supressora de Tumor p53 Limite: Adult / Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article